Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $11,734 | $2,920 | $9,977 | $3,708 |
Gross Profit | 11,734 | -68,109 | -47,294 | -52,364 |
EBITDA | -57,095 | -77,433 | -70,204 | -65,959 |
EBIT | -58,851 | -79,129 | -61,892 | -67,663 |
Net Income | -59,100 | -78,952 | -60,754 | -51,854 |
Net Change In Cash | 11,734 | 2,920 | 9,977 | 3,708 |
Free Cash Flow | -71,847 | -73,284 | -87,307 | -9,764 |
Cash | 648,325 | 721,451 | 792,972 | 879,520 |
Basic Shares | 69,303 | 69,252 | 69,196 | 69,051 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $35,275 | $26,976 | $14,463 | $11,697 |
Gross Profit | -137,691 | -129,520 | 14,463 | 11,697 |
EBITDA | -164,892 | -183,400 | -107,208 | -64,089 |
EBIT | -172,069 | -189,946 | -110,897 | -65,498 |
Net Income | -169,031 | -180,664 | -112,717 | -66,819 |
Net Change In Cash | 35,275 | 26,976 | 14,463 | 11,697 |
Free Cash Flow | -165,959 | -63,557 | -105,098 | -16,824 |
Cash | 879,520 | 526,423 | 339,154 | 438,680 |
Basic Shares | 58,207 | 35,592 | 29,660 | 25,061 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.85 |
2025-06-30 | -$1.14 |
2025-03-31 | -$0.88 |
2024-12-31 | -$0.81 |
